Watch John Oliver Slam Drug Companies for the Opioid Epidemic

His brutal takedown is brilliant.


John Oliver’s latest episode of Last Week Tonight takes on the pharmaceutical companies that laid the foundation for today’s opioid overdose epidemic, which claimed the lives of nearly 30,000 Americans in 2014.

Oliver points out that until the 1990s, doctors were wary of prescribing opioids to treat pain because of lingering concerns about their addictive qualities. But prescribing shot up in the late ’90s, largely due to a massive marketing campaign launched by Purdue Pharma, which introduced OxyContin in 1995. Doctors were assured that prescribing OxyContin for chronic pain was safe, and that dependence on the drugs was merely “pseudo-addiction.” (Oliver: “That is like Chipotle saying, ‘Have you hard of this fascinating new thing called pseudo-diarrhea?…The cure may actually be more tacos!'”)

“This is the perfect choice of mascot, because much like a guerilla, OxyContin might seem appealing, but if you’re not careful, it will tear your fucking life apart.”

In addition to educational materials, doctors were offered all sorts of OxyContin swag, from swing music CDs to fishing caps. Pulling out a plush OxyContin stuffed toy guerrilla, Oliver says, “This is the perfect choice of mascot, because much like a guerilla, OxyContin might seem appealing, but if you’re not careful, it will tear your fucking life apart.”

Curbing the epidemic will be a massive lift, involving prescribing less painkillers and providing resources for those already addicted. “It won’t be cheap, it won’t be quick, and it won’t be easy,” says Oliver. “And it is hard not to be angry at the drug companies like Purdue whose promises of cheap, quick, easy pain solutions helped put us in this fucking mess.”

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate